Cargando…

Necessity for retrospective evaluation of past-positive chemicals in in vitro chromosomal aberration tests using recommended cytotoxicity indices

We have demonstrated that retrospective evaluation of existing data of in vitro chromosomal aberration test using the new cytotoxicity indices RICC (relative increase in cell count) or RPD (relative population doubling) reduces the false-positive rate. We have constructed an algorithm to predict the...

Descripción completa

Detalles Bibliográficos
Autores principales: Honda, Hiroshi, Fujita, Yurika, Kasamatsu, Toshio, Fuchs, Anne, Fautz, Rolf, Morita, Osamu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5761126/
https://www.ncbi.nlm.nih.gov/pubmed/29339977
http://dx.doi.org/10.1186/s41021-017-0091-y
_version_ 1783291505596694528
author Honda, Hiroshi
Fujita, Yurika
Kasamatsu, Toshio
Fuchs, Anne
Fautz, Rolf
Morita, Osamu
author_facet Honda, Hiroshi
Fujita, Yurika
Kasamatsu, Toshio
Fuchs, Anne
Fautz, Rolf
Morita, Osamu
author_sort Honda, Hiroshi
collection PubMed
description We have demonstrated that retrospective evaluation of existing data of in vitro chromosomal aberration test using the new cytotoxicity indices RICC (relative increase in cell count) or RPD (relative population doubling) reduces the false-positive rate. We have constructed an algorithm to predict the likelihood that past-positive results would differ when retested accordingly. Here, we emphasize the importance of reviewing existing in vitro chromosomal aberration test results. The present Letter not only supports the rediscovery of potentially useful chemicals excluded from further development as a result of misclassification due to in vitro false-positive results, but also contributes to the development of a precise Quantitative Structure-Activity Relationship (QSAR) model by providing an appropriate training data-set. Furthermore, re-evaluation is expected to provide novel insights into underlying mechanisms and/or key structures involved in the development of chromosomal aberrations.
format Online
Article
Text
id pubmed-5761126
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-57611262018-01-16 Necessity for retrospective evaluation of past-positive chemicals in in vitro chromosomal aberration tests using recommended cytotoxicity indices Honda, Hiroshi Fujita, Yurika Kasamatsu, Toshio Fuchs, Anne Fautz, Rolf Morita, Osamu Genes Environ Letter to the Editor We have demonstrated that retrospective evaluation of existing data of in vitro chromosomal aberration test using the new cytotoxicity indices RICC (relative increase in cell count) or RPD (relative population doubling) reduces the false-positive rate. We have constructed an algorithm to predict the likelihood that past-positive results would differ when retested accordingly. Here, we emphasize the importance of reviewing existing in vitro chromosomal aberration test results. The present Letter not only supports the rediscovery of potentially useful chemicals excluded from further development as a result of misclassification due to in vitro false-positive results, but also contributes to the development of a precise Quantitative Structure-Activity Relationship (QSAR) model by providing an appropriate training data-set. Furthermore, re-evaluation is expected to provide novel insights into underlying mechanisms and/or key structures involved in the development of chromosomal aberrations. BioMed Central 2018-01-10 /pmc/articles/PMC5761126/ /pubmed/29339977 http://dx.doi.org/10.1186/s41021-017-0091-y Text en © The Author(s) 2018 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Letter to the Editor
Honda, Hiroshi
Fujita, Yurika
Kasamatsu, Toshio
Fuchs, Anne
Fautz, Rolf
Morita, Osamu
Necessity for retrospective evaluation of past-positive chemicals in in vitro chromosomal aberration tests using recommended cytotoxicity indices
title Necessity for retrospective evaluation of past-positive chemicals in in vitro chromosomal aberration tests using recommended cytotoxicity indices
title_full Necessity for retrospective evaluation of past-positive chemicals in in vitro chromosomal aberration tests using recommended cytotoxicity indices
title_fullStr Necessity for retrospective evaluation of past-positive chemicals in in vitro chromosomal aberration tests using recommended cytotoxicity indices
title_full_unstemmed Necessity for retrospective evaluation of past-positive chemicals in in vitro chromosomal aberration tests using recommended cytotoxicity indices
title_short Necessity for retrospective evaluation of past-positive chemicals in in vitro chromosomal aberration tests using recommended cytotoxicity indices
title_sort necessity for retrospective evaluation of past-positive chemicals in in vitro chromosomal aberration tests using recommended cytotoxicity indices
topic Letter to the Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5761126/
https://www.ncbi.nlm.nih.gov/pubmed/29339977
http://dx.doi.org/10.1186/s41021-017-0091-y
work_keys_str_mv AT hondahiroshi necessityforretrospectiveevaluationofpastpositivechemicalsininvitrochromosomalaberrationtestsusingrecommendedcytotoxicityindices
AT fujitayurika necessityforretrospectiveevaluationofpastpositivechemicalsininvitrochromosomalaberrationtestsusingrecommendedcytotoxicityindices
AT kasamatsutoshio necessityforretrospectiveevaluationofpastpositivechemicalsininvitrochromosomalaberrationtestsusingrecommendedcytotoxicityindices
AT fuchsanne necessityforretrospectiveevaluationofpastpositivechemicalsininvitrochromosomalaberrationtestsusingrecommendedcytotoxicityindices
AT fautzrolf necessityforretrospectiveevaluationofpastpositivechemicalsininvitrochromosomalaberrationtestsusingrecommendedcytotoxicityindices
AT moritaosamu necessityforretrospectiveevaluationofpastpositivechemicalsininvitrochromosomalaberrationtestsusingrecommendedcytotoxicityindices